Regenxbio Inc
Change company Symbol lookup
Select an option...
RGNX Regenxbio Inc
OGSYS Otis Gallery LLC
RDN Radian Group Inc
SLNO Soleno Therapeutics Inc
REI Ring Energy Inc
FSHOX Fidelity® Select Construction & Housing Portfolio
NNN NNN REIT Inc
UTHR United Therapeutics Corp
KEX Kirby Corp
DDOG Datadog Inc
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

REGENXBIO Inc. is a clinical-stage biotechnology company, which is focused on providing curative potential of gene therapy. Its investigational gene therapies are designed to deliver functional genes to address genetic defects in cells. The Company’s investigational AAV Therapeutics include RGX-314, RGX-202, RGX-121, RGX-111 and RGX-181 and RGX-381. RGX-314 is meant for the treatment of large patient populations impacted by wet age-related macular degeneration (wet AMD), diabetic retinopathy and other chronic retinal diseases. RGX-202 is developed to treat Duchenne muscular dystrophy, one of the common fatal genetic disorders affecting children. RGX-121, RGX-111 and RGX-181 are developed to treat Mucopolysaccharidosis type II, Mucopolysaccharidosis type I, and late infantile neuronal ceroid lipofuscinosis type II (CLN2 disease), all of which are progressive, neurodegenerative lysosomal storage disorders. RGX-381 is developed to treat the ocular manifestations of CLN2 disease.

Closing Price
$18.56
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Average)
Volume:
434,410

10-day average volume:
466,934
434,410

HP Doubles Down on Partner Growth with Groundbreaking Program Enhancements

9:00 am ET March 29, 2023 (Globe Newswire) Print
HP Doubles Down on Partner Growth with Groundbreaking Program EnhancementsGlobeNewswireMarch 29, 2023

HP kicks off global Amplify Partner Conference with future-ready strategy for driving greater collaboration and benefits

News Highlights

  • Announces Amplify for All - integration of Poly, Teradici and HyperX into HP Amplify program
  • Reveals plan to welcome Distribution partners to HP Amplify in FY24
  • Unveils new More for More compensation and Fast Lane joint demand generation process1
  • Introduces new incentive towards track eligibility for HP Amplify Impact partners

CHICAGO, March 29, 2023 (GLOBE NEWSWIRE) -- Today at the Amplify(TM) Partner Conference, HP Inc (NYSE: HPQ) announced several new partner benefits and program enhancements aimed at driving greater agility, simplification, growth and collaboration. As of November 1, 2023 (fiscal 2024), all HP products, solutions and distribution across its vast portfolio will be integrated into the HP Amplify Program, delivering one global2 platform as the foundation for partner engagement.

"The HP Amplify program represents the industry's first to reward partners across performance, capabilities and collaboration and we're looking forward to integrating our evolving and expanding portfolio into the Amplify Partner Program as of our new fiscal year," said Kobi Elbaz, General Manager, HP Global Channel Organization. "Amplify will continue to serve as the foundation for partner engagement and we will continue to enhance the program based on the evolution of our portfolio, changing market dynamics and most importantly, partner feedback."

HP also unveiled two new elements in the HP Amplify program, including the More for More benefit and compensation program, and Fast Lane joint demand generation process. Aimed at driving an increase in sales across the HP portfolio and deliver a more satisfying and complete customer experience, the More for More enhancement will leverage a rate multiplier to boost compensation for qualified partners. The new Fast Lane joint demand generation process simplifies reimbursement of marketing development funds via an automated process for claims and payments, dramatically improving the turn-around time and overall experience for eligible partners1. Both the More for More and Fast Lane elements will be deployed in the Amplify partner program in HP's new fiscal year, November 1, 2023.

Rewarding Partners for Investment in Sustainable Impact

HP Amplify Impact represents the world's first partner assessment, resource, and training program focused solely on Sustainable Impact. To help spur the company's ambitious goal of enrolling at least 50 percent of Amplify partners in Amplify Impact by 2025, HP today announced a new way for participating partners to leverage Amplify Impact participation towards eligibility status. Beginning May 2023, qualified partners receiving 3-Star recognition will earn a point towards eligibility for Power and Power Services.

HP also honored winners of its inaugural Amplify Impact Awards at a live ceremony today at the Amplify Partner Conference.

About HP Amplify

Launched in November 2020, HP Amplify represents the first global partner program optimized to drive dynamic partner growth and deliver consistent end customer experiences and outcomes. It delivers a simplified and easy-to-navigate global structure, which rewards partners based on three pillars: performance, collaboration and capabilities. Since the launch of HP Amplify, HP has expanded the program with Amplify Data Insights, Amplify Retail, Amplify Online and Amplify Impact.

For more information on HP Amplify, visit our newsroom.

About HP

HP Inc. (NYSE: HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operating in more than 170 countries, HP delivers a wide range of innovative and sustainable devices, services and subscriptions for personal computing, printing, 3D printing, hybrid work, gaming, and more. For more information, please visit: http://www.hp.com.

Media Contacts

HP Media Relations

MediaRelations@hp.com

hp.com/go/newsroom



Resources:

1 HP Amplify More for More and Fast Lane elements based on partner eligibility requirements

2 All geographic markets apart from Greater China





Primary Logo

comtex tracking

COMTEX_427857634/2010/2023-03-29T09:00:07

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.